United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund Invests $34.10 Million in Cigna Group $CI

Key Points

• United Super Pty Ltd took a new position in Cigna Group, buying 123,888 shares worth about $34.1 million in the fourth quarter.
• Cigna’s CEO David Cordani sold 201,878 shares in a pre-arranged trading plan, and insiders have sold a total of about $60.3 million in stock over the past 90 days.
• The company posted better-than-expected Q1 results, with EPS of $7.79 versus $7.60 expected and revenue of $68.52 billion, while also announcing a quarterly dividend of $1.56 per share.

United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund acquired a new position in shares of Cigna Group (NYSE:CI - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 123,888 shares of the health services provider's stock, valued at approximately $34,098,000.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in CI. Brighton Jones LLC increased its holdings in Cigna Group by 9.3% in the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider's stock valued at $1,032,000 after buying an additional 318 shares in the last quarter. Sivia Capital Partners LLC lifted its stake in shares of Cigna Group by 10.4% in the second quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider's stock worth $384,000 after buying an additional 109 shares in the last quarter. NewEdge Advisors LLC grew its stake in Cigna Group by 4.5% during the 2nd quarter. NewEdge Advisors LLC now owns 22,225 shares of the health services provider's stock valued at $7,347,000 after acquiring an additional 958 shares in the last quarter. Treasurer of the State of North Carolina grew its stake in Cigna Group by 16.6% during the 2nd quarter. Treasurer of the State of North Carolina now owns 148,840 shares of the health services provider's stock valued at $49,204,000 after acquiring an additional 21,173 shares in the last quarter. Finally, Osterweis Capital Management Inc. purchased a new position in Cigna Group during the second quarter worth about $163,000. Institutional investors and hedge funds own 86.99% of the company's stock.

Insider Buying and Selling

In related news, CEO David Cordani sold 201,878 shares of the company's stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the sale, the chief executive officer directly owned 34,337 shares of the company's stock, valued at $10,054,560.34. This represents a 85.46% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 1,719 shares of the company's stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $496,636.29. Following the sale, the insider directly owned 5,670 shares in the company, valued at approximately $1,638,119.70. The trade was a 23.26% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 205,904 shares of company stock valued at $60,277,068 in the last ninety days. Company insiders own 0.60% of the company's stock.

Cigna Group Price Performance

Shares of CI opened at $284.62 on Friday. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $338.89. The firm's 50 day moving average price is $278.07 and its 200 day moving average price is $276.88. The company has a market cap of $75.29 billion, a P/E ratio of 12.07, a PEG ratio of 1.03 and a beta of 0.30. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.69.

Cigna Group (NYSE:CI - Get Free Report) last announced its earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, topping the consensus estimate of $7.60 by $0.19. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The firm had revenue of $68.52 billion for the quarter, compared to the consensus estimate of $66.29 billion. During the same period in the prior year, the firm earned $6.74 EPS. The firm's revenue for the quarter was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, research analysts forecast that Cigna Group will post 30.39 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, June 18th. Investors of record on Thursday, June 4th will be paid a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a yield of 2.2%. The ex-dividend date of this dividend is Thursday, June 4th. Cigna Group's dividend payout ratio is presently 26.45%.

Analyst Ratings Changes

A number of equities analysts have commented on CI shares. Wells Fargo & Company lifted their target price on shares of Cigna Group from $300.00 to $305.00 and gave the stock an "equal weight" rating in a research note on Friday, May 1st. Royal Bank Of Canada lifted their target price on shares of Cigna Group from $333.00 to $337.00 and gave the stock an "outperform" rating in a research note on Friday, May 1st. Mizuho set a $330.00 price target on shares of Cigna Group in a research note on Friday, May 1st. UBS Group upped their price objective on shares of Cigna Group from $375.00 to $400.00 and gave the stock a "buy" rating in a report on Friday, May 22nd. Finally, Guggenheim upped their price objective on shares of Cigna Group from $334.00 to $338.00 and gave the stock a "buy" rating in a report on Monday, May 4th. One research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $339.50.

Cigna Group Profile

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.